|
|
||||||||
1From the Center for Human Genetics Research and the 3Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, Tennessee; and the 2Center for Human Genetics and the Department of Medicine and 4Duke University Eye Center and the Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina.
PURPOSE. Age-related macular degeneration (AMD) is a retinal degenerative disease that is the leading cause of blindness worldwide for individuals over the age of 60. Although the etiology of AMD remains largely unknown, numerous studies have suggested that both genes and environmental risk factors significantly influence the risk of developing AMD. Identification of the underlying genes has been difficult, with both genomic screen (locational) and candidate gene (functional) approaches being used. The present study tested candidate genes for association with AMD.
METHODS. Eight genes (
-2-macroglobulin [A2M], creatine kinase [CKB], angiotensin-converting enzyme [DCP1], interleukin-1
[IL1A], low-density lipoprotein receptorrelated protein 6 [LRP6], microsomal glutathione-S-transferase 1 [MGST1], vascular entothelial growth factor [VEGF], and very low density lipoprotein receptor [VLDLR]) were tested for genetic linkage and allelic association, using two independent datasets: a family-based association dataset including 162 families and an independent case-control dataset with 399 cases and 159 fully evaluated controls.
RESULTS. Test results suggested that genetic variation in five of these genes (IL1A, CKB, A2M, MGST1, and DCP1) is unlikely to explain a significant fraction of the risk of developing AMD in this population. LRP6 showed evidence both for linkage (heterogeneity lod [HLOD] = 1.14) in the family-based dataset and for association (P = 0.004) in the case-control dataset. VEGF showed evidence of linkage (HLOD = 1.32) and demonstrated significant independent allelic association in both the family-based (P = 0.001) and case-control (P = 0.02) datasets. VLDLR showed evidence of association in both the family based (P = 0.03) and case-control (P = 0.01) datasets.
CONCLUSIONS. These data suggest that LRP6, VEGF, and VLDLR may play a role in the risk of developing AMD.
This article has been cited by other articles:
![]() |
A. J. Churchill, J. G. Carter, C. Ramsden, S. J. Turner, A. Yeung, P. E. C. Brenchley, and D. W. Ray VEGF Polymorphisms Are Associated with Severity of Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3611 - 3616. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Crawford, A. S. Nord, M. D. Badzioch, J. Ranchalis, L. A. McKinstry, M. Ahearn, C. Bertucci, C. Shephard, M. Wong, M. J. Rieder, et al. A common VLDLR polymorphism interacts with APOE genotype in the prediction of carotid artery disease risk J. Lipid Res., March 1, 2008; 49(3): 588 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hu, A. Jiang, J. Liang, H. Meng, B. Chang, H. Gao, and X. Qiao Expression of VLDLR in the Retina and Evolution of Subretinal Neovascularization in the Knockout Mouse Model's Retinal Angiomatous Proliferation Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 407 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, Y. Hu, K. Lu, J. G. Flannery, and J.-x. Ma Very Low Density Lipoprotein Receptor, a Negative Regulator of the wnt Signaling Pathway and Choroidal Neovascularization J. Biol. Chem., November 23, 2007; 282(47): 34420 - 34428. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Swaroop, K. E. Branham, W. Chen, and G. Abecasis Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits Hum. Mol. Genet., October 15, 2007; 16(R2): R174 - R182. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Thompson, B. E.K. Klein, R. Klein, Z. Xu, J. Capriotti, T. Joshi, D. Leontiev, K. E. Lee, R. C. Elston, and S. K. Iyengar Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes Hum. Mol. Genet., September 1, 2007; 16(17): 2135 - 2148. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Al-Kateb, L. Mirea, X. Xie, L. Sun, M. Liu, H. Chen, S. B. Bull, A. P. Boright, A. D. Paterson, and for the DCCT/EDIC Research Group Multiple Variants in Vascular Endothelial Growth Factor (VEGFA) Are Risk Factors for Time to Severe Retinopathy in Type 1 Diabetes: The DCCT/EDIC Genetics Study Diabetes, August 1, 2007; 56(8): 2161 - 2168. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. V. De Ferrari, A. Papassotiropoulos, T. Biechele, F. Wavrant De-Vrieze, M. E. Avila, M. B. Major, A. Myers, K. Saez, J. P. Henriquez, A. Zhao, et al. Common genetic variation within the Low-Density Lipoprotein Receptor-Related Protein 6 and late-onset Alzheimer's disease PNAS, May 29, 2007; 104(22): 9434 - 9439. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Churchill, J. G. Carter, H. C. Lovell, C. Ramsden, S. J. Turner, A. Yeung, J. Escardo, and D. Atan VEGF polymorphisms are associated with neovascular age-related macular degeneration Hum. Mol. Genet., October 1, 2006; 15(19): 2955 - 2961. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |